Bulletin
Investor Alert

Market Pulse Archives

May 25, 2022, 8:27 a.m. EDT

Genocea Biosciences to shut down

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Genocea Biosciences Inc. (GNCA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Genocea Biosciences Inc. /zigman2/quotes/200216704/composite GNCA -3.18% on Tuesday told investors it plans to shut down and lay off all remaining employees. The company said it gave notice to The Nasdaq Stock Market Inc. for its plans to voluntarily delist its common stock and said it plans to file a Form 25 with the Securities and Exchange Commission by June 2. Genocea was developing immunotherapies for people with cancer. The company's stock had tumbled 94.7% this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +3.06% is down 17.3%.

/zigman2/quotes/200216704/composite
US : U.S.: OTC
$ 0.02
-0.0006 -3.18%
Volume: 266,749
June 24, 2022 3:59p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$984,624
Rev. per Employee
$25,824
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,911.74
+116.01 +3.06%
Volume: 3.46B
June 24, 2022 5:05p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.